Asylia Diagnostics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
Asylia Diagnostics General Information
Description
Developer of molecular diagnostics tests designed to provide safer immunotherapy for cancer patients. The company's approach is based on a transformative concept that leverages molecular and clinical RWE data and machine learning/AI, allowing de-risk upfront theranostic development, identifying non-responders to SoC, dissecting patient strata, and finding relevant biomarkers and novel targets to offer precision medicine systems for patients, enabling cancer patients to avail better and faster diagnosis.
Contact Information
Website
www.asyliadx.comCorporate Office
- JLABS at BE, Janssen Pharmaceutica NV Beerse Site 1
- Turnhoutseweg 30
- 2340 Beerse
- Belgium
Corporate Office
- JLABS at BE, Janssen Pharmaceutica NV Beerse Site 1
- Turnhoutseweg 30
- 2340 Beerse
- Belgium
Asylia Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 5. Later Stage VC | 18-Feb-2025 | Completed | Clinical Trials - Phase 1 | |||
| 4. Seed Round | 25-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 02-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 16-Sep-2019 | $55.3K | $55.3K | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 01-Jan-2019 | Completed | Startup |
Asylia Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Asylia Diagnostics Comparisons
Industry
Financing
Details
Asylia Diagnostics Competitors (2)
One of Asylia Diagnostics’s 2 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| GRAIL | Formerly VC-backed | Menlo Park, CA |
Asylia Diagnostics Patents
Asylia Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022315526-A1 | Biomarkers for therapy response after immunotherapy | Pending | 22-Jul-2021 | ||
| EP-4373974-A1 | Biomarkers for therapy response after immunotherapy | Active | 22-Jul-2021 | ||
| EP-4373974-B1 | Biomarkers for therapy response after immunotherapy | Active | 22-Jul-2021 | ||
| EP-4373974-C0 | Biomarkers for therapy response after immunotherapy | Active | 22-Jul-2021 | ||
| ES-3073634-T3 | Biomarkers for therapy response after immunotherapy | Active | 22-Jul-2021 | C12Q1/6886 |
Asylia Diagnostics Signals
Asylia Diagnostics Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AstraZeneca | Corporation | Minority | ||
| Az Alma | Corporation | Minority | ||
| Becton, Dickinson and Company | Corporation | Minority | ||
| Biocartis Group | Corporation | Minority | ||
| Tempus AI | Corporation | Minority |
Asylia Diagnostics FAQs
-
When was Asylia Diagnostics founded?
Asylia Diagnostics was founded in 2019.
-
Where is Asylia Diagnostics headquartered?
Asylia Diagnostics is headquartered in Beerse, Belgium.
-
What is the size of Asylia Diagnostics?
Asylia Diagnostics has 8 total employees.
-
What industry is Asylia Diagnostics in?
Asylia Diagnostics’s primary industry is Discovery Tools (Healthcare).
-
Is Asylia Diagnostics a private or public company?
Asylia Diagnostics is a Private company.
-
What is Asylia Diagnostics’s current revenue?
The current revenue for Asylia Diagnostics is .
-
How much funding has Asylia Diagnostics raised over time?
Asylia Diagnostics has raised $1.66M.
-
Who are Asylia Diagnostics’s investors?
AstraZeneca, Az Alma, Becton, Dickinson and Company, Biocartis Group, and Tempus AI are 5 of 11 investors who have invested in Asylia Diagnostics.
-
Who are Asylia Diagnostics’s competitors?
Foundation Medicine and GRAIL are competitors of Asylia Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process